Azzad Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.95M | Buy |
31,610
+427
| +1% | +$91.9K | 0.7% | 21 |
|
|
2026
Q1 | $6.78M | Sell |
31,183
-253
| -0.8% | -$56.1K | 0.69% | 20 |
|
|
2025
Q4 | $7.18M | Buy |
31,436
+231
| +0.7% | +$52.6K | 0.7% | 18 |
|
|
2025
Q3 | $7.23M | Sell |
31,205
-7
| -0% | -$1.43K | 0.71% | 15 |
|
|
2025
Q2 | $5.79M | Buy |
31,212
+6,563
| +27% | +$1.22M | 0.62% | 26 |
|
|
2025
Q1 | $5.16M | Sell |
24,649
-37
| -0.1% | -$7.19K | 0.61% | 26 |
|
|
2024
Q4 | $4.39M | Buy |
24,686
+621
| +3% | +$114K | 0.85% | 24 |
|
|
2024
Q3 | $4.75M | Sell |
24,065
-255
| -1% | -$47.6K | 0.53% | 44 |
|
|
2024
Q2 | $4.17M | Buy |
24,320
+991
| +4% | +$164K | 0.49% | 50 |
|
|
2024
Q1 | $4.25M | Buy |
23,329
+11,009
| +89% | +$1.9M | 0.5% | 54 |
|
|
2023
Q4 | $1.91M | Sell |
12,320
-147
| -1% | -$21.4K | 0.24% | 159 |
|
|
2023
Q3 | $1.86M | Buy |
12,467
+216
| +2% | +$31.7K | 0.26% | 154 |
|
|
2023
Q2 | $1.65M | Buy |
12,251
+621
| +5% | +$91.1K | 0.22% | 167 |
|
|
2023
Q1 | $1.85M | Buy |
11,630
+1,535
| +15% | +$235K | 0.26% | 147 |
|
|
2022
Q4 | $1.63M | Buy |
10,095
+4,208
| +71% | +$645K | 0.26% | 158 |
|
|
2022
Q3 | $733K | Buy |
+5,887
| New | +$845K | 0.07% | 308 |
|
|
2020
Q2 | – | Sell |
-34,874
| Closed | -$2.66M | – | 291 |
|
|
2020
Q1 | $2.66M | Sell |
34,874
-2,585
| -7% | -$220K | 0.77% | 17 |
|
|
2019
Q4 | $3.33M | Buy |
37,459
+1,186
| +3% | +$98.5K | 0.39% | 88 |
|
|
2019
Q3 | $2.78M | Buy |
36,273
+4,437
| +14% | +$304K | 0.34% | 97 |
|
|
2019
Q2 | $2.32M | Buy |
31,836
+4,898
| +18% | +$385K | 0.64% | 34 |
|
|
2019
Q1 | $2.17M | Buy |
26,938
+1,593
| +6% | +$130K | 0.63% | 37 |
|
|
2018
Q4 | $2.34M | Buy |
25,345
+1,801
| +8% | +$158K | 0.79% | 16 |
|
|
2018
Q3 | $2.23M | Buy |
23,544
+327
| +1% | +$31K | 0.6% | 34 |
|
|
2018
Q2 | $2.15M | Buy |
23,217
+1,552
| +7% | +$152K | 0.62% | 29 |
|
|
2018
Q1 | $2.05M | Buy |
21,665
+16,888
| +354% | +$1.86M | 0.62% | 34 |
|
|
2017
Q4 | $462K | Buy |
+4,777
| New | +$450K | 0.15% | 210 |
|
|
2015
Q4 | – | Sell |
-22,121
| Closed | -$1.23M | – | 235 |
|
|
2015
Q3 | $1.23M | Buy |
22,121
+2,053
| +10% | +$134K | 0.65% | 35 |
|
|
2015
Q2 | $1.35M | Sell |
20,068
-5,099
| -20% | -$333K | 0.68% | 28 |
|
|
2015
Q1 | $1.47M | Buy |
25,167
+6,052
| +32% | +$366K | 0.71% | 25 |
|
|
2014
Q4 | $1.25M | Buy |
19,115
+725
| +4% | +$45.7K | 0.66% | 29 |
|
|
2014
Q3 | $1.06M | Buy |
18,390
+1,004
| +6% | +$55.7K | 0.61% | 32 |
|
|
2014
Q2 | $981K | Buy |
17,386
+2,202
| +15% | +$116K | 0.59% | 37 |
|
|
2014
Q1 | $780K | Buy |
15,184
+1,316
| +9% | +$66.5K | 0.51% | 59 |
|
|
2013
Q4 | $732K | Buy |
13,868
+825
| +6% | +$40.5K | 0.53% | 57 |
|
|
2013
Q3 | $583K | Hold |
13,043
| – | – | 0.48% | 72 |
|
|
2013
Q2 | $577K | Buy |
+13,043
| New | +$570K | 0.49% | 65 |
|
Other funds holding ABBV
ECSS
ATO
Azzad Asset Management's ABBV Position: Q2 2026 in Review
Azzad Asset Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $91.9K and bringing the position to 31,610 shares worth $7.95M. The position accounts for 0.7% of the portfolio, ranked #21.
Azzad Asset Management first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Azzad Asset Management held 31,610 shares of AbbVie worth $7.95M as of Q2 2026.
- Azzad Asset Management bought 427 AbbVie shares in Q2 2026, an estimated $91.9K.
- AbbVie made up 0.7% of Azzad Asset Management's portfolio in Q2 2026, its #21 holding.
- Azzad Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.